Home
>
National Drug Code (NDC)
>
Clindamycin
Clindamycin - 0409-4050-01 - (CLINDAMYCIN PHOSPHATE)
Drug Information of Clindamycin
| Product NDC: | 0409-4050 |
| Proprietary Name: | Clindamycin |
| Non Proprietary Name: | CLINDAMYCIN PHOSPHATE |
| Active Ingredient(s): | 150 mg/mL & nbsp; CLINDAMYCIN PHOSPHATE |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Clindamycin
| Product NDC: | 0409-4050 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA062800 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19870724 |
Package Information of Clindamycin
| Package NDC: | 0409-4050-01 |
| Package Description: | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-4050-01) > 2 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of Clindamycin
| NDC Code | 0409-4050-01 |
| Proprietary Name | Clindamycin |
| Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-4050-01) > 2 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0409-4050 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CLINDAMYCIN PHOSPHATE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 19870724 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | CLINDAMYCIN PHOSPHATE |
| Strength Number | 150 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |
